Nuo Therapeutics
(OTC) AURX
Nuo Therapeutics Financials at a Glance
Market Cap
$60.10M
Revenue (TTM)
$2.61M
Net Income (TTM)
$2.43M
EPS (TTM)
$-0.05
P/E Ratio
-24.13
Dividend
$0.00
Beta (Volatility)
-38.42 (Low)
Dividend
$0.00
Beta (Volatility)
-38.42 (Low)
Price
$1.25
Volume
582
Open
$1.25
Price
$1.25
Volume
582
Open
$1.25
Previous Close
$1.25
Daily Range
$1.25 - $1.25
52-Week Range
$0.94 - $3.23
Dividend
$0.00
Beta (Volatility)
-38.42 (Low)
Price
$1.25
Volume
582
Open
$1.25
Previous Close
$1.25
Daily Range
$1.25 - $1.25
52-Week Range
$0.94 - $3.23
AURX News
AURX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
9
CEO
David Emerson Jorden, CFA, MBA
Website
www.nuot.comHeadquarters
Houston, TX 77054, US
AURX Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
-98%
Net Income Margin
-93%
Return on Equity
-1032%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-4.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$60.10M
Shares Outstanding
48.08M
Volume
582
Short Interest
0.00%
Avg. Volume
2.67K
Financials (TTM)
Gross Profit
$1.06M
Operating Income
$2.46M
EBITDA
$2.36M
Operating Cash Flow
$2.23M
Capital Expenditure
$154.96K
Free Cash Flow
$2.39M
Cash & ST Invst.
$283.71K
Total Debt
$164.21K
Nuo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.03M
+178.2%
Gross Profit
$625.38K
+131.2%
Gross Margin
60.59%
N/A
Market Cap
$60.10M
N/A
Market Cap/Employee
$6.68M
N/A
Employees
9
N/A
Net Income
$537.92K
+7.0%
EBITDA
$496.29K
+10.9%
Quarterly Fundamentals
Net Cash
$400.11K
-20.7%
Accounts Receivable
$652.25K
+98.1%
Inventory
$201.63K
+20.2%
Long Term Debt
$40.76K
-64.5%
Short Term Debt
$73.94K
+14.4%
Return on Assets
-1.26%
N/A
Return on Invested Capital
-3.82%
N/A
Free Cash Flow
$706.52K
-10.7%
Operating Cash Flow
$706.52K
-44.9%